Drugs / dropropizine
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT01199497 | Aug 2011 → Aug 2012 | nasal cavity disorder | Ache Laboratorios Farmaceuticos S.A. | Withdrawn | No outcome recorded |
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT01177852 Background | Oct 2011 → Apr 2012 | rhinitis | Ache Laboratorios Farmaceuticos S.A. | Withdrawn | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | dropropizine | “fixed dose combination of diphenhydramine + dropropizine + pseudoephedrine (Notuss® syrup).” NCT01199497 ↗ |
| Route | Oral | “Used Orally for Evaluation” NCT01177852 ↗ |